PDT Partners, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1564702 New York, NY

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,791,608

-$290,401 QoQ

Shares Held

28,781

0.0% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PDT Partners, LLC holds $31,971,918 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	563,440	$5,363,948
2	INDV	Indivior Pharmaceuticals, Inc.	142,792	$4,352,300
3	SUPN	Supernus Pharmaceuticals, Inc.	76,673	$3,963,227
4	KNSA	Kiniksa Pharmaceuticals International, plc	80,263	$3,864,663
5	NBIX	Neurocrine Biosciences Inc This page	28,781	$3,791,608
6	ANIP	Ani Pharmaceuticals Inc	45,442	$3,494,489
7	PCRX	Pacira BioSciences, Inc.	132,368	$2,991,516
8	AMRX	Amneal Pharmaceuticals, Inc.	180,628	$2,245,206

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,791,608	28,781	0.0%	Shares	Sole	2026-05-15
2025-12-31	$4,082,009	28,781	-30.8%	Shares	Sole	2026-02-17
2025-09-30	$5,840,369	41,604	-0.0%	Shares	Sole	2025-11-17
2025-06-30	$5,229,332	41,605	+126.1%	Shares	Sole	2025-08-14
2025-03-31	$2,035,593	18,405	-47.0%	Shares	Sole	2025-05-15
2024-12-31	$4,743,102	34,748	+133.2%	Shares	Sole	2025-02-14
2024-09-30	$1,716,778	14,900	+60.1%	Shares	Sole	2024-11-14
2023-09-30	$1,046,925	9,306	-11.5%	Shares	Sole	2023-11-14
2023-06-30	$991,281	10,512	+27.3%	Shares	Sole	2023-08-14
2022-09-30	$876,763	8,255	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.